IPN-60090 ( IACS-6274; IPN60090) is a novel, potent, orally bioavailable and specific inhibitor of GLS1 (the kidney-type glutaminase), which is an important enzyme for metabolic energy production. IPN-60090 can be used in the research of GLS1-mediated diseases. It also has potential anticancer and immunostimulating/immunomodulating activities. IPN60090 selectively targets, binds to and inhibits human glutaminase, an enzyme that is essential for the conversion of the amino acid glutamine into glutamate.

纯度：≥98%

CAS：1853164-83-6